Abstract
Objective
to assess the levels and determinants of interleukin (IL)-1β, IL-6, tumour necrosis factor (TNF)-α and C-reactive protein (CRP) in a healthy Caucasian population.
Methods
population sample of 2884 men and 3201 women aged 35 to 75. IL-1β, IL-6 and TNF-α were assessed by a multiplexed particle-based flow cytometric assay and CRP by an immunometric assay.
Results
Spearman rank correlations between duplicate cytokine measurements (N = 80) ranged between 0.89 and 0.96; intra-class correlation coefficients ranged between 0.94 and 0.97, indicating good reproducibility. Among the 6085 participants, 2289 (37.6%), 451 (7.4%) and 43 (0.7%) had IL-1β, IL-6 and TNF-α levels below detection limits, respectively. Median (interquartile range) for participants with detectable values were 1.17 (0.48–3.90) pg/ml for IL-1β; 1.47 (0.71–3.53) pg/ml for IL-6; 2.89 (1.82–4.53) pg/ml for TNF-α and 1.3 (0.6–2.7) ng/ml for CRP. On multivariate analysis, greater age was the only factor inversely associated with IL-1β levels. Male sex, increased BMI and smoking were associated with greater IL-6 levels, while no relationship was found for age and leisure-time PA. Male sex, greater age, increased BMI and current smoking were associated with greater TNF-α levels, while no relationship was found with leisure-time PA. CRP levels were positively related to age, BMI and smoking, and inversely to male sex and physical activity.
Conclusion
Population-based levels of several cytokines were established. Increased age and BMI, and to a lesser degree sex and smoking, significantly and differentially impact cytokine levels, while leisure-time physical activity has little effect.
Introduction
Proinflammatory cytokines, such as interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF)-α and the acute phase reactant C-reactive protein (CRP) have important effects in inflammation and atherosclerosis. Elevated levels of these inflammatory biomarkers have been associated with an increased risk of developing incident coronary heart disease [1]–[3].
Several studies have shown that cytokine levels can be mediated by several lifestyle factors such as smoking [4] and physical activity [4]–[6]. Still, contrary to the considerable data regarding the contribution of cytokines to atherothrombotic diseases, little information is available regarding the distribution of cytokine levels and their determinants within a population-based sample [7], [8].
Hence, we used the data from the large, population-based CoLaus study to 1) assess cytokine levels in an apparently healthy, population-based Caucasian adult sample and 2) assess the independent effects of sex, age, BMI, smoking and physical activity on cytokine levels. To our knowledge, this is currently the largest population study that has cytokines levels measured.
Methods
Ethics statement
The CoLaus Study was approved by the Institutional Ethics Committee of the University of Lausanne (decision 19 February 2003, protocol number 16/03). Written informed consent was obtained from all participants.
Recruitment
The CoLaus Study is a cross-sectional study aimed at assessing the prevalence of CVD risk factors as the molecular determinants of CVD in the Caucasian population of Lausanne, Switzerland, a town of 117,161 inhabitants, of which 79,420 are of Swiss nationality. The sampling procedure of the CoLaus Study has previously been described [9]. Recruitment began in June 2003 and ended in May 2006. Participation rate was 41%.
All participants attended the outpatient clinic of the University Hospital of Lausanne in the morning after an overnight fast. Data were collected by trained field interviewers in a single visit lasting about 60 min. No information regarding revenues or social deprivation was collected.
Lifestyle and clinical data
Participants were classified as never, current, or former smokers. A participant was considered as physically active if he/she reported practicing at least 2 hours of leisure-time physical activity per week.
Body weight and height were measured with participants standing without shoes in light indoor clothes. Body weight was measured in kilograms to the nearest 100 g using a Seca® scale, regularly calibrated. Height was measured to the nearest 5 mm using a Seca® height gauge. Overweight was defined as a BMI ≥25 and <30 kg.m−2; obesity was defined as a BMI ≥30 kg.m−2.
Cytokine measurement
Venous blood samples (50 mL) were drawn in the fasting state and allowed to clot. Serum was preferred to plasma as it has been shown that different anticoagulants may affect absolute cytokine levels differently [10], [11]. High sensitive CRP (hs-CRP) was assessed by immunoassay and latex HS (IMMULITE 1000–High, Diagnostic Products Corporation, LA, CA, USA) with maximum intra- and interbatch coefficients of variation of 1.3% and 4.6%, respectively. Serum samples were kept at −80°C before assessment of IL-1β, IL-6, and TNF-α and sent in dry ice to the laboratory. Levels of these cytokines were measured using a multiplexed particle-based flow cytometric cytokine assay [12]. This methodology yields cytokine concentrations which correlate well with those obtained by other methods such as ELISA [13] (for a review, see [14]). Milliplex kits were purchased from Millipore (Zug, Switzerland). The procedures closely followed the manufacturer's instructions. The analysis was conducted using a conventional flow cytometer (FC500 MPL, BeckmanCoulter, Nyon, Switzerland). Lower limits of detection (LOD) for IL-1β, IL-6 and TNF-α were 0.2 pg/ml. A good agreement between signal and cytokine was found within the assay range (R2≥0.99). Intra and inter-assay coefficients of variation were respectively 15% and 16.7% for IL-1β, 16.9% and 16.1% for IL-6 and 12.5% and 13.5% for TNF-α. For quality control, repeated measurements were conducted in 80 subjects randomly drawn from the initial sample.
Statistical analysis
Statistical analysis was conducted using SAS v.9.2 (SAS Inc, Cary, NC, USA). Reproducibility between the first and the second measurement was assessed by Spearman nonparametric correlation, intraclass correlation coefficients, Lin's concordance correlation and Bland-Altman plots. Lin's concordance correlation measures how well a new set of observations reproduces an original set and has been reported to be more appropriate than other indices for measuring agreement when the variable of interest is continuous. Quantitative variables (apart from inflammatory biomarkers) were expressed as mean ± standard deviation and qualitative variables as number of participants and (percentage). Biomarkers were presented as median and (interquartile range) of measured values, percentage of values below LOD and percentage of values within each quartile. Undetectable values were included in the first quartile. Between groups comparisons were performed using Student t-test or Kruskall-Wallis nonparametric test for quantitative and chi-square test for qualitative variables. The relationships between biomarker values (excluding undetectable ones) and selected quantitative variables (i.e. age and BMI) were assessed using Spearman's nonparametric correlation; similar analyses were performed replacing values below LOD by a) half the limit of detection [15] and b) multiple imputation of missing data using a Markov Chain Monte Carlo method [16] and five imputation sets. Multivariate analysis was conducted by multivariate linear regression using log-transformed cytokine values as dependent variable, a method used elsewhere [4]. Two models were applied: the first using only measured data, the second replacing values below LOD by half the limit of detection. The results were expressed as slope and (standard error). We also used multivariate logistic regression to assess the likelihood of being in the topmost quartile compared to the other three quartiles as well as being in the topmost vs. the lowest quartile of cytokine distribution. Results of the logistic analysis were presented as Odds-ratio (OR) and (95% confidence interval). Statistical significance was considered for p<0.05.
Results
Clinical characteristics of participants
Of the 6,188 initial participants, 6,085 (98.3%, 2884 men and 3201 women) could be assessed for inflammatory biomarkers while for the remaining 103 participants (1.7%) no blood samples were available. Compared to women, men were older (52.6±10.8 vs. 53.5±10.7 years, p<0.001), had a higher BMI (26.6±4.0 vs. 25.1±4.8 kg/m2, p<0.001) and smoked more (32.3%, 38.6% and 29.1% for never, former and current smokers, respectively, vs. 47.3, 28.0 and 24.7%, p<0.001). Conversely, leisure-time physical activity was similar between sexes (men: 64.2%, women: 65.0%; p = 0.51).
Reproducibility of cytokine measurements
Spearman rank correlations (N = 80) between duplicate measurements were 0.914, 0.961 and 0.891 for IL-1β, IL-6 and TNF-α (all p<0.001), respectively, while Lin's correlation coefficients were 0.969, 0.971 and 0.945 and intra-class correlation coefficients were 0.970, 0.972 and 0.946 for IL-1β, IL-6 and TNF-α, respectively (all p<0.001), indicating a good reproducibility. Bland-Altman plots also showed good average agreement (not shown).
Distribution of cytokine levels
Among the 6085 participants, 2289 (37.6%), 451 (7.4%) and 43 (0.7%) had IL-1ß, Il-6 and TNF-α levels below LOD, respectively. The distribution of measured IL-1β, IL-6, TNF-α and hs-CRP levels according to different criteria is summarized in Tables 1 , 2 , 3 and 4 , respectively.
Table 1. Interleukin-1β distribution according to different parameters.
All | Dosable | Median,pg/ml | % below | % in quartile | ||||
N | N | (IQR) | LOD | 1 | 2 | 3 | 4 | |
All subjects | 6085 | 3796 | 1.17(0.48–3.90) | 37.6 | 37.6 | 20.7 | 20.5 | 21.2 |
Sex | ||||||||
Men | 2884 | 1746 | 1.08(0.45–3.96) | 39.5 | 39.5 | 21.7 | 18.9 | 20.0 |
Women | 3201 | 2050 | 1.28(0.52–3.79) | 36.0 | 36.0 | 19.8 | 22.0 | 22.2 |
Test | 4.33* | 7.93** | 18.37*** | |||||
Age group (years) | ||||||||
[35–44] | 1714 | 1172 | 1.32(0.54–4.30) | 31.6 | 31.6 | 20.8 | 22.6 | 25.0 |
[45–54] | 1734 | 1103 | 1.26(0.48–3.98) | 36.4 | 36.4 | 20.7 | 20.3 | 22.6 |
[55–64] | 1677 | 1007 | 1.02(0.44–3.27) | 40.0 | 40.0 | 21.7 | 20.2 | 18.2 |
[65–75] | 960 | 514 | 1.13(0.45–3.55) | 46.5 | 46.5 | 18.9 | 17.7 | 17.0 |
Test | 14.61** | 63.24*** | 77.72*** | |||||
BMI categories | ||||||||
Normal | 2925 | 1874 | 1.32(0.53–4.09) | 35.9 | 35.9 | 19.3 | 22.0 | 22.8 |
Overweight | 2222 | 1357 | 1.06(0.45–3.90) | 38.9 | 38.9 | 22.2 | 18.5 | 20.3 |
Obese | 938 | 565 | 1.03(0.45–2.91) | 39.8 | 39.8 | 21.4 | 20.8 | 18.0 |
Test | 10.35* | 7.02* | 26.21*** | |||||
Smoking status | ||||||||
Never | 2445 | 1536 | 1.17(0.51–3.70) | 37.2 | 37.2 | 20.2 | 21.7 | 20.9 |
Former | 2009 | 1229 | 1.10(0.45–3.82) | 38.8 | 38.8 | 21.7 | 19.2 | 20.3 |
Current | 1631 | 1031 | 1.27(0.49–4.46) | 36.8 | 36.8 | 20.2 | 20.4 | 22.6 |
Test | 4.49NS | 1.93NS | 8.57NS | |||||
Leisure-time PA | ||||||||
No | 2156 | 1369 | 1.19(0.47–3.82) | 36.5 | 36.5 | 21.0 | 21.6 | 20.9 |
Yes | 3929 | 2427 | 1.17(0.49–3.93) | 38.2 | 38.2 | 20.5 | 20.0 | 21.3 |
Test | 0.01NS | 1.77NS | 3.13NS |
Results are expressed as median and (interquartile range, IQR) for values over detection level, and as % (all subjects). BMI, body mass index; CVD, cardiovascular disease; LOD, limits of detection; PA, physical activity. Statistical analysis by Kruskall-Wallis nonparametric test (for medians) and by chi-square (for percentages):
, not significant;
*, p<0.05;
**, p<0.01;
***, p<0.001.
Table 2. Interleukin-6 distribution according to different parameters.
All | Dosable | Median,pg/ml | % below | % in quartile | ||||
N | N | (IQR) | LOD | 1 | 2 | 3 | 4 | |
All subjects | 6085 | 5634 | 1.47(0.71–3.53) | 7.4 | 25.1 | 24.8 | 25.1 | 25.0 |
Sex | ||||||||
Men | 2884 | 2697 | 1.59(0.77–3.84) | 6.5 | 22.3 | 24.4 | 26.0 | 27.3 |
Women | 3201 | 2937 | 1.37(0.67–3.23) | 8.2 | 27.5 | 25.1 | 24.4 | 23.0 |
Test | 19.62*** | 6.87** | 29.17*** | |||||
Age group (years) | ||||||||
[35–44] | 1714 | 1550 | 1.38(0.65–3.51) | 9.6 | 29.5 | 23.6 | 22.6 | 24.3 |
[45–54] | 1734 | 1594 | 1.41(0.69–3.54) | 8.1 | 26.2 | 25.6 | 23.3 | 24.9 |
[55–64] | 1677 | 1579 | 1.52(0.71–3.40) | 5.8 | 23.8 | 25.0 | 26.3 | 24.9 |
[65–75] | 960 | 911 | 1.70(0.90–3.68) | 5.1 | 17.3 | 24.9 | 30.8 | 27.0 |
Test | 18.36*** | 26.18*** | 61.68*** | |||||
BMI categories | ||||||||
Normal | 2925 | 2652 | 1.36(0.64–3.46) | 9.3 | 29.6 | 24.0 | 22.3 | 24.1 |
Overweight | 2222 | 2075 | 1.45(0.73–3.37) | 6.6 | 23.8 | 26.2 | 25.7 | 24.4 |
Obese | 938 | 907 | 1.96(0.99–4.04) | 3.3 | 14.1 | 23.6 | 32.6 | 29.7 |
Test | 47.58*** | 40.85*** | 113.74*** | |||||
Smoking status | ||||||||
Never | 2445 | 2235 | 1.32(0.65–3.11) | 8.6 | 28.6 | 25.6 | 23.7 | 22.1 |
Former | 2009 | 1853 | 1.50(0.71–3.61) | 7.8 | 25.6 | 24.4 | 24.6 | 25.4 |
Current | 1631 | 1546 | 1.73(0.86–4.06) | 5.2 | 19.2 | 24.0 | 27.8 | 29.0 |
Test | 39.69*** | 16.81*** | 61.20*** | |||||
Leisure-time PA | ||||||||
No | 2156 | 2027 | 1.63(0.77–3.68) | 6.0 | 22.0 | 24.2 | 27.3 | 26.5 |
Yes | 3929 | 3607 | 1.41(0.69–3.42) | 8.2 | 26.7 | 25.1 | 23.9 | 24.3 |
Test | 11.03*** | 9.93** | 21.86*** |
Results are expressed as median and (interquartile range, IQR) for values over detection level, and as % (all subjects). BMI, body mass index; CVD, cardiovascular disease; LOD, limits of detection; PA, physical activity. Statistical analysis by Kruskall-Wallis nonparametric test (for medians) and by chi-square (for percentages):
**, p<0.01;
***, p<0.001.
Table 3. Tumor Necrosis Factor-α distribution according to different parameters.
All | Dosable | Median,pg/ml | % below | % in quartile | ||||
N | N | (IQR) | LOD | 1 | 2 | 3 | 4 | |
All subjects | 6085 | 6042 | 2.89(1.82–4.53) | 0.7 | 25.2 | 24.7 | 25.2 | 24.9 |
Sex | ||||||||
Men | 2884 | 2865 | 3.05(1.90–4.65) | 0.7 | 23.1 | 23.9 | 27.1 | 26.0 |
Women | 3201 | 3177 | 2.75(1.73–4.42) | 0.7 | 27.2 | 25.5 | 23.4 | 23.9 |
Test | 22.59*** | 0.18NS | 22.89*** | |||||
Age group (years) | ||||||||
[35–44] | 1714 | 1701 | 2.59(1.66–4.08) | 0.8 | 29.7 | 27.3 | 22.0 | 21.1 |
[45–54] | 1734 | 1719 | 2.87(1.76–4.44) | 0.9 | 26.9 | 23.8 | 25.3 | 24.0 |
[55–64] | 1677 | 1667 | 3.04(1.94–4.63) | 0.6 | 22.5 | 24.3 | 27.4 | 25.8 |
[65–75] | 960 | 955 | 3.31(2.11–5.18) | 0.5 | 19.1 | 22.6 | 26.8 | 31.6 |
Test | 74.70*** | 1.45NS | 81.07*** | |||||
BMI categories | ||||||||
Normal | 2925 | 2901 | 2.70(1.71–4.21) | 0.8 | 27.9 | 26.2 | 24.2 | 21.7 |
Overweight | 2222 | 2209 | 2.97(1.85–4.61) | 0.6 | 24.5 | 23.8 | 25.8 | 25.9 |
Obese | 938 | 932 | 3.41(2.13–5.27) | 0.6 | 18.7 | 22.5 | 26.8 | 32.1 |
Test | 66.54*** | 1.07NS | 64.78*** | |||||
Smoking status | ||||||||
Never | 2445 | 2430 | 2.79(1.76–4.42) | 0.6 | 26.5 | 25.9 | 24.1 | 23.4 |
Former | 2009 | 1988 | 2.97(1.84–4.54) | 1.0 | 24.9 | 23.8 | 26.4 | 24.9 |
Current | 1631 | 1624 | 3.00(1.87–4.80) | 0.4 | 23.7 | 24.0 | 25.3 | 27.0 |
Test | 11.39** | 5.38NS | 13.03* | |||||
Leisure-time PA | ||||||||
No | 2156 | 2140 | 2.99(1.85–4.76) | 0.7 | 25.0 | 23.1 | 25.1 | 26.9 |
Yes | 3929 | 3902 | 2.85(1.81–4.45) | 0.7 | 25.4 | 25.6 | 25.3 | 23.8 |
Test | 5.68* | 0.06NS | 9.24* |
Results are expressed as median and (interquartile range, IQR) for values over detection level, and as % (all subjects). BMI, body mass index; CVD, cardiovascular disease; LOD, limits of detection; PA, physical activity. Statistical analysis by Kruskall-Wallis nonparametric test (for medians) and by chi-square (for percentages):
, not significant;
*, p<0.05;
**, p<0.01;
***, p<0.001.
Table 4. High sensitive-CRP distribution according to different parameters.
All | Dosable | Median,pg/ml | % in quartile | ||||
N | N | (IQR) | 1 | 2 | 3 | 4 | |
All subjects | 6085 | 6084 | 1.3 (0.6–2.7) | 21.9 | 29.8 | 22.4 | 25.8 |
Sex | |||||||
Men | 2884 | 2883 | 1.2 (0.6–2.6) | 22.0 | 31.1 | 23.3 | 23.6 |
Women | 3201 | 3201 | 1.3 (0.6–2.9) | 21.9 | 28.7 | 21.6 | 27.8 |
Test | 6.16** | 15.15** | |||||
Age group (years) | |||||||
[35–44] | 1714 | 1713 | 1.0 (0.4–2.2) | 31.3 | 29.9 | 17.3 | 21.5 |
[45–54] | 1734 | 1734 | 1.1 (0.6–2.4) | 24.0 | 32.8 | 20.9 | 22.3 |
[55–64] | 1677 | 1677 | 1.5 (0.7–3.1) | 15.5 | 29.6 | 25.3 | 29.5 |
[65–75] | 960 | 960 | 1.8 (0.9–3.4) | 12.6 | 24.8 | 29.2 | 33.4 |
Test | 226.8*** | 254.3*** | |||||
BMI categories | |||||||
Normal | 2925 | 2924 | 0.8 (0.4–1.7) | 33.9 | 33.8 | 17.7 | 14.6 |
Overweight | 2222 | 2222 | 1.6 (0.8–3.1) | 13.4 | 30.4 | 26.6 | 29.6 |
Obese | 938 | 938 | 2.8 (1.5–5.5) | 4.9 | 16.2 | 27.1 | 51.8 |
Test | 929.2*** | 916.2*** | |||||
Smoking status | |||||||
Never | 2445 | 2445 | 1.2 (0.6–2.6) | 23.0 | 30.5 | 21.6 | 24.8 |
Former | 2009 | 2009 | 1.3 (0.6–2.7) | 21.9 | 30.1 | 22.8 | 25.3 |
Current | 1631 | 1630 | 1.4 (0.7–2.9) | 20.4 | 28.5 | 23.2 | 28.0 |
Test | 13.6** | 9.81NS | |||||
Leisure-time PA | |||||||
No | 2156 | 2156 | 1.6 (0.7–3.5) | 16.6 | 27.0 | 24.4 | 32.0 |
Yes | 3929 | 3928 | 1.1 (0.6–2.4) | 24.8 | 31.4 | 21.4 | 22.4 |
Test | 119.88*** | 106.94*** |
Results are expressed as median and (interquartile range, IQR) for values over detection level, and as % (all subjects). BMI, body mass index; CVD, cardiovascular disease; LOD, limits of detection; PA, physical activity. Statistical analysis by Kruskall-Wallis nonparametric test (for medians) and by chi-square (for percentages):
, not significant;
**, p<0.01;
***, p<0.001.
For IL-1β, lower levels (and higher percentage of subjects below detection values) were found in men and with increasing age or BMI, while no differences were found between the three smoking groups or with increasing leisure-time physical activity ( Table 1 ). IL-1β values were inversely related with age and BMI, and positively with IL-6 and TNF-α, while no relationship was found with CRP (Table S6). For IL-6, higher levels (and lower percentage of subjects below the LOD) were found in men, with increasing age and BMI, among current smokers and sedentary subjects ( Table 2 ). Significant positive correlations were found between IL-6 and age, BMI, TNF-α and CRP (Table S1). For TNF-α, higher levels were found in men, with increasing age and BMI, among smokers and sedentary subjects ( Table 3 ). As for IL-6, significant correlations were found between TNF-α values and age, BMI and CRP (Table S1). For hs-CRP, higher levels were found in women, with increasing age and BMI and among smokers, while lower levels were found in subjects who reported leisure-time physical activity ( Table 4 ). Positive relationships were found between hs-CRP values and age and BMI (Table S1).
The relationship of cytokine levels (including the proportion of undetectable values) with age differed considerably across biomarkers and by sex (Figure S1). IL-1β linearly decreased with age in both sexes, women having higher levels than men at all age groups. IL-6 levels tended to be higher at greater ages in both sexes, but the association with age was not linear and tended to be steeper in men than in women. TNF-α levels increased with age in men in a nearly linear manner, whereas the increase in women occurred mainly around the age of menopause. For hs-CRP, the age-related increase was linear in men and S-shaped in women.
Multivariate analysis of the factors related with cytokine levels
The results of the multivariate linear regression analysis are summarized in Table 5 . Multivariate analysis assessing the likelihood of being in the topmost a higher quartile compared to the lower other quartiles of cytokine distribution was performed using ordinal logistic regression. For IL-1β, older age were significantly, independently and inversely related with IL-1β levels, while no associations were found for the other variables. For IL-6, male sex, increased BMI and smoking status were independently and positively related with IL-6 levels, while no significant association was found for age and leisure-time physical activity. For TNF-α, male sex, older age, increased BMI and current smoking were positively related with TNF-α, while no association were found for leisure-time physical activity. Finally, for hs-CRP, increasing age, and BMI and current smoking were positively related while male sex and leisure-time physical activity were negatively associated with hs-CRP levels ( Table 5 ). These findings were further confirmed by multivariate logistic regression modeling the likelihood of being in the highest vs. the others or the lowest quartiles, and including values below LOD in the lowest quartile (Table S2 and Table S3). Including values below LOD further showed an inverse association between male sex and IL-1β levels and a positive association between age and (Table S2 and Table S3).
Table 5. Multivariate linear regression using log-transformed values of cytokines.
IL-1β | IL-6 | TNF-α | CRP | |
Men(yes vs. no) | −0.0638(0.0495) | 0.0756(0.0366)* | 0.0517(0.0228)* | −0.2210(0.0261)*** |
Age | −0.0077(0.0023) *** | 0.0029(0.0017) | 0.0071(0.0011)*** | 0.0128(0.0012)*** |
BMI | −0.0074(0.0055) | 0.0224(0.0041)*** | 0.0163(0.0026)*** | 0.0969(0.0029)*** |
Former smoker(yes vs. no) | 0.0080(0.0572) | 0.0965(0.0425)* | 0.0297(0.0264) | −0.0030(0.0301) |
Current smoker(yes vs. no) | 0.1118(0.0605) | 0.2524(0.0450)*** | 0.1165(0.0280)*** | 0.2327(0.0321)*** |
Leisure-time PA(yes vs. no) | −0.0035(0.0512) | −0.0276(0.0378) | −0.0063(0.0236) | −0.1520(0.0270)*** |
Results are expressed as slope and (standard error). BMI, body mass index; hs-CRP, high sensitive C reactive protein; IL-1β, interleukin-1β; IL-6, interleukin-6; PA, physical activity; TNF-α, tumor necrosis factor-α. Statistical analysis by linear regression on log-transformed cytokine values:
*, p<0.05;
***, p<0.001.
Results after replacement of undetectable values
As a significant number of participants had cytokine levels below LOD, further analyses were conducted replacing values below LOD by half the LOD or using multivariate imputation as described. The results are summarized in supplemental tables 4 to 6. Overall, and as observed using measured values only, IL-1β values were inversely related with age and BMI, and positively with IL-6 and TNF-α, while no relationship was found with CRP (Table S4 and Table S5). Similarly, the results of the multivariate linear regression analysis were comparable with these using only measured data, with the exception of an inverse association between male sex and IL-1β levels and a positive association between age and IL-6 levels (Table S6), a finding also observed using multivariate logistic regression (Table S2 and Table S3).
Discussion
There are few population studies providing information on cytokines [7], [17]. To our knowledge, this is one of the largest population-based studies which assessed the distributions and determinants of circulating inflammatory biomarkers. Our results thus provide important information regarding the distribution of levels of these biomarkers in the Caucasian adult population, which could serve as reference values for further studies.
The reproducibility of the IL-1β, IL-6 and TNF-α assays was adequate, with between-measurement correlation coefficients higher than 0.9 and a good reproducibility. The intra- and inter-batch CVs were also below the reference 20% threshold [18], although higher thresholds have been used for cytokine assessments [19]. All samples were kept at −80°C before assessment. It has been shown that IL-6 and TNF-α levels kept at −70°C correspond to the initial values [20]. Interestingly, the correlation coefficients between IL-1β, IL-6 and TNF-α found in this study were in close agreement with the values reported previously, even after missing value replacement [21], [22] and the IL-6 and TNF-α values obtained using this methodology were comparable to the literature (Figure S2 and Figure S3). Finally, the fact that the CoLaus study used the same methodology on the same platform for all samples at baseline is of importance, as it has been shown that the results of cytokine assessment can differ considerably between platforms [19]. Overall, our data indicate that the cytokine measurements used in this study are reproducible and provide values and relationships in agreement with the literature.
In this study, circa 38% of participants had IL-1β below detection levels, a value lower than reported previously [21], [23]. This difference cannot be solely attributed to a lower detection threshold (0.2 pg/ml) of the method used in this study, as it is actually higher than reported in other studies (0.1 pg/ml) [23]. Likely explanations include the use of plasma instead of serum [21]; different blood collection periods [24] or the type of anticoagulation used [21]. Overall, it would be helpful that each study reports the percentage of participants below detection levels as well as the method used (kit and serum or plasma samples), in order to adequately compare levels across studies.
To our knowledge, there has been little information regarding the factors influencing IL-1β levels at the population level. In this study, men had lower IL-1β levels than women, and this difference remained after multivariate adjustment. Hence, our results are not in agreement with previous studies suggesting that men have higher percentage of IL-1β secreting monocytes than women [25]. Increased age was also associated with lower IL-1β levels, and this difference persisted after multivariate adjustment. This is, to our knowledge, the first report providing the distribution of IL-1β by age and sex groups in the general population. Despite being a pro-inflammatory cytokine positively correlated with IL-6 and TNF-α, both of which increase with age, IL-1β levels were lower at older ages. Again, these findings do not confirm a previous study in which IL-1β levels were suggested to be similar between young and elderly subjects [22]. Contrary to a previous study [26], no relationship was found between personal history of CVD and IL-1β levels, possibly due to CVD treatment or to the fact that some participants presented their CVD event a long time ago. Conversely, the absence of relationship between IL-1β levels and leisure-time physical activity is in agreement with the literature [27]. Overall, our data indicate that IL-1β levels are positively, independently and significantly influenced by age and to a lesser degree by sex, but not by BMI, smoking or physical activity.
Men had higher IL-6 values than women, and this difference remained after multivariate adjustment, contradicting previous statements suggesting that the sex difference in IL-6 levels could be due to differences in adiposity [28]. Increased BMI and current smoking were also positively related with IL-6 levels, confirming previous findings [4]. Indeed, in healthy subjects, about 30% of circulating IL-6 originates from adipose tissue [29]. In agreement with some studies [30], but not with others [31], no significant independent relationship was found between age and IL-6 after multivariate adjustment. On bivariate analysis, lower IL-6 levels were found among participants who reported leisure-time physical activity, but this relationship became nonsignificant after multivariate analysis. Our results are in agreement with some studies [27], but not with others [6], suggesting that exercise reduces IL-6 independently from adiposity. Further, some authors have suggested that muscle contraction increases IL-6 levels, which then would act as an anti-inflammatory agent [32]. Overall, our data indicate that IL-6 levels are positively, independently and significantly influenced by sex, smoking status and increased BMI levels, while the effects of age and leisure-time (and overall) physical activity need further clarification.
Male sex and greater age, increased BMI and current smoking were independently and positively associated with TNF-α levels, a finding in agreement with the literature [33]. Contrary to some studies [5], but in agreement with others [27], no independent relationship between leisure-time physical activity and TNF-α levels was found. Again, it is possible that this relationship is mediated by exercise-induced changes in BMI, but further studies are needed to better assess this point. Overall, our data indicate that TNF-α levels are positively, independently and significantly influenced by male sex, age, smoking status and increased BMI levels, while the effects of and leisure-time physical activity need further clarification.
Significant positive relationships were found between hs-CRP levels, IL-6 and TNF-α, a finding already reported [34], although the strength of the relationship was lower in this study. Conversely, no relationships were found between hs-CRP and IL-1ß levels. CRP was positively and independently related with age, increased BMI and smoking, a finding reported previously [4]. Since adipose tissue can produce IL-6 [29], which in turn increases CRP production, it could be inferred that part of the relationship between BMI and hs-CRP could be mediated by high IL-6 levels; still, after adjusting for IL-6, the partial Spearman correlation between hs-CRP and BMI was virtually unchanged (0.398 instead of 0.408). The strength of the relationship between hs-CRP and BMI was also considerably higher than the relationships between BMI and the other cytokines, suggesting that the relationships between the different cytokines and BMI appear to be graded and rather complex. Finally, the negative relationship between hs-CRP and leisure-time physical activity is in agreement with some studies [6], [27] but not with others [4]. Overall, our data indicate that hs-CRP levels are positively related with age, increasing BMI and smoking, and negatively related with male sex and leisure-time physical activity.
This study has some limitations worth pointing out. The participation rate was low (41%), which might limit the generalization of the findings; however, this participation rate is similar to other epidemiological studies [35]. Also, no data on non-Caucasian participants were available; therefore our findings may not apply to other ethnicities. Further, only data from leisure-time physical activity was available. Hence, it is likely that this sole information may be not sufficient to detect any impact on levels of pro-inflammatory cytokines. Further studies with a better assessment of overall physical activity are needed to clarify the association between physical activity and pro-inflammatory cytokines. The major strength of our study is that we used a large, population-based sample representative of the Swiss population, and that a precise characterization of the participants was performed.
Conclusion
In summary, we provide population-based reference levels of several cytokines; these levels could be used for comparison with other specific groups. Our results also indicate that, in this population-based sample, levels of inflammatory biomarkers of atherothrombotic risk seem robustly influenced by age and increased BMI and to a lesser degree by sex and smoking, while the lower effect of leisure-time physical activity awaits further clarification.
Supporting Information
Acknowledgments
The authors express their gratitude to the participants in the Lausanne CoLaus study and to the investigators who have contributed to the recruitment, in particular Yolande Barreau, Anne-Lise Bastian, Binasa Ramic, Martine Moranville, Martine Baumer, Marcy Sagette, Jeanne Ecoffey and Sylvie Mermoud for data collection. M Bochud is supported by the Swiss School of Public Health Plus (SSPH+).
Footnotes
Competing Interests: Peter Vollenweider and Gérard Waeber received an unrestricted grant for GSK to build the CoLaus study. The other authors report no competing interests. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Funding: The CoLaus study was supported by research grants from the Swiss National Science Foundation (grant no: 33CSCO-122661) from GlaxoSmithKline and the Faculty of Biology and Medicine of Lausanne, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843. doi: 10.1056/NEJM200003233421202. [DOI] [PubMed] [Google Scholar]
- 2.Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA. 2002;288:980–987. doi: 10.1001/jama.288.8.980. [DOI] [PubMed] [Google Scholar]
- 3.Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med. 2008;5:e78. doi: 10.1371/journal.pmed.0050078. 10.1371/journal.pmed.0050078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol. 2002;22:1668–1673. doi: 10.1161/01.atv.0000029781.31325.66. [DOI] [PubMed] [Google Scholar]
- 5.Colbert LH, Visser M, Simonsick EM, Tracy RP, Newman AB, et al. Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2004;52:1098–1104. doi: 10.1111/j.1532-5415.2004.52307.x. 10.1111/j.1532-5415.2004.52307.x. [DOI] [PubMed] [Google Scholar]
- 6.Fischer CP, Berntsen A, Perstrup LB, Eskildsen P, Pedersen BK. Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity. Scand J Med Sci Sports. 2007;17:580–587. doi: 10.1111/j.1600-0838.2006.00602.x. 10.1111/j.1600-0838.2006.00602.x. [DOI] [PubMed] [Google Scholar]
- 7.Welsh P, Woodward M, Rumley A, Lowe G. Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study. Br J Haematol. 2008;141:852–861. doi: 10.1111/j.1365-2141.2008.07133.x. 10.1111/j.1365-2141.2008.07133.x. [DOI] [PubMed] [Google Scholar]
- 8.Stowe RP, Peek MK, Cutchin MP, Goodwin JS. Plasma cytokine levels in a population-based study: relation to age and ethnicity. J Gerontol A Biol Sci Med Sci. 2010;65:429–433. doi: 10.1093/gerona/glp198. 10.1093/gerona/glp198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Firmann M, Mayor V, Marques-Vidal P, Bochud M, Pécoud A, et al. The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord. 2008;8:6. doi: 10.1186/1471-2261-8-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Flower L, Ahuja RH, Humphries SE, Mohamed-Ali V. Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine. 2000;12:1712–1716. doi: 10.1006/cyto.2000.0764. 10.1006/cyto.2000.0764. [DOI] [PubMed] [Google Scholar]
- 11.Skeppholm M, Wallén NH, Blombäck M, Kallner A. Can both EDTA and citrate plasma samples be used in measurements of fibrinogen and C-reactive protein concentrations? Clin Chem Lab Med. 2008;46:1175–1179. doi: 10.1515/CCLM.2008.219. 10.1515/CCLM.2008.219. [DOI] [PubMed] [Google Scholar]
- 12.Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods. 2000;243:243–255. doi: 10.1016/s0022-1759(00)00238-6. [DOI] [PubMed] [Google Scholar]
- 13.dupont NC, Wang K, Wadhwa PD, Culhane JF, Nelson EL. Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol. 2005;66:175–191. doi: 10.1016/j.jri.2005.03.005. 10.1016/j.jri.2005.03.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Elshal MF, McCoy JP. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods. 2006;38:317–323. doi: 10.1016/j.ymeth.2005.11.010. 10.1016/j.ymeth.2005.11.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Hornung R, Reed L. Estimation of average concentration in the presence of nondectable values. Appl Occup Environ Hyg. 1990;5:46–51. [Google Scholar]
- 16.Schafer JL. Analysis of incomplete multivariate data. New York: Chapman & Hall; 1997. 430 [Google Scholar]
- 17.Scuteri A, Orru M, Morrell C, Piras MG, Taub D, et al. Independent and additive effects of cytokine patterns and the metabolic syndrome on arterial aging in the SardiNIA Study. Atherosclerosis. 2011;215:459–464. doi: 10.1016/j.atherosclerosis.2010.12.023. 10.1016/j.atherosclerosis.2010.12.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Fichorova RN, Richardson-Harman N, Alfano M, Belec L, Carbonneil C, et al. Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study. Anal Chem. 2008;80:4741–4751. doi: 10.1021/ac702628q. 10.1021/ac702628q. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Chowdhury F, Williams A, Johnson P. Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling. J Immunol Methods. 2009;340:55–64. doi: 10.1016/j.jim.2008.10.002. 10.1016/j.jim.2008.10.002. [DOI] [PubMed] [Google Scholar]
- 20.Friebe A, Volk HD. Stability of tumor necrosis factor alpha, interleukin 6, and interleukin 8 in blood samples of patients with systemic immune activation. Arch Pathol Lab Med. 2008;132:1802–1806. doi: 10.5858/132.11.1802. [DOI] [PubMed] [Google Scholar]
- 21.Wong HL, Pfeiffer RM, Fears TR, Vermeulen R, Ji S, et al. Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiol Biomarkers Prev. 2008;17:3450–3456. doi: 10.1158/1055-9965.EPI-08-0311. 10.1158/1055-9965.EPI-08-0311. [DOI] [PubMed] [Google Scholar]
- 22.Roubenoff R, Harris TB, Abad LW, Wilson PW, Dallal GE, et al. Monocyte cytokine production in an elderly population: effect of age and inflammation. J Gerontol A Biol Sci Med Sci. 1998;53:M20–M26. doi: 10.1093/gerona/53a.1.m20. [DOI] [PubMed] [Google Scholar]
- 23.Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes. 2003;52:812–817. doi: 10.2337/diabetes.52.3.812. [DOI] [PubMed] [Google Scholar]
- 24.DeRijk R, Michelson D, Karp B, Petrides J, Galliven E, et al. Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6. J Clin Endocrinol Metab. 1997;82:2182–2191. doi: 10.1210/jcem.82.7.4041. [DOI] [PubMed] [Google Scholar]
- 25.Bouman A, Schipper M, Heineman MJ, Faas MM. Gender difference in the non-specific and specific immune response in humans. Am J Reprod Immunol. 2004;52:19–26. doi: 10.1111/j.1600-0897.2004.00177.x. 10.1111/j.1600-0897.2004.00177.x. [DOI] [PubMed] [Google Scholar]
- 26.Balbay Y, Tikiz H, Baptiste RJ, Ayaz S, Sasmaz H, et al. Circulating interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and soluble ICAM-1 in patients with chronic stable angina and myocardial infarction. Angiology. 2001;52:109–114. doi: 10.1177/000331970105200204. [DOI] [PubMed] [Google Scholar]
- 27.Stewart LK, Flynn MG, Campbell WW, Craig BA, Robinson JP, et al. The influence of exercise training on inflammatory cytokines and C-reactive protein. Med Sci Sports Exerc. 2007;39:1714–1719. doi: 10.1249/mss.0b013e31811ece1c. 10.1249/mss.0b013e31811ece1c. [DOI] [PubMed] [Google Scholar]
- 28.Cartier A, Côté M, Lemieux I, Pérusse L, Tremblay A, et al. Sex differences in inflammatory markers: what is the contribution of visceral adiposity? Am J Clin Nutr. 2009;89:1307–1314. doi: 10.3945/ajcn.2008.27030. 10.3945/ajcn.2008.27030. [DOI] [PubMed] [Google Scholar]
- 29.Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 1997;82:4196–4200. doi: 10.1210/jcem.82.12.4450. [DOI] [PubMed] [Google Scholar]
- 30.Cartier A, Côté M, Lemieux I, Pérusse L, Tremblay A, et al. Age-related differences in inflammatory markers in men: contribution of visceral adiposity. Metabolism. 2009;58:1452–1458. doi: 10.1016/j.metabol.2009.04.025. 10.1016/j.metabol.2009.04.025. [DOI] [PubMed] [Google Scholar]
- 31.Hager K, Machein U, Krieger S, Platt D, Seefried G, et al. Interleukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiol Aging. 1994;15:771–772. doi: 10.1016/0197-4580(94)90066-3. [DOI] [PubMed] [Google Scholar]
- 32.Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol. 2005;98:1154–1162. doi: 10.1152/japplphysiol.00164.2004. 10.1152/japplphysiol.00164.2004. [DOI] [PubMed] [Google Scholar]
- 33.Moon YS, Kim DH, Song DK. Serum tumor necrosis factor-alpha levels and components of the metabolic syndrome in obese adolescents. Metabolism. 2004;53:863–867. doi: 10.1016/j.metabol.2004.02.007. [DOI] [PubMed] [Google Scholar]
- 34.Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999;19:972–978. doi: 10.1161/01.atv.19.4.972. [DOI] [PubMed] [Google Scholar]
- 35.Tolonen H, Koponen P, Aromaa A, Conti S, Graff-Iversen S, et al. Review of health examination surveys in Europe. 2008;B18/2008:1–379. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.